- Home
- ACHV vs CFBK Comparison
ACHV vs CFBK Comparison
Compare ACHV & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- CFBK
- Stock Information
- Founded
- ACHV N/A
- CFBK 1892
- Country
- ACHV United States
- CFBK United States
- Employees
- ACHV N/A
- CFBK N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CFBK Major Banks
- Sector
- ACHV Health Care
- CFBK Finance
- Exchange
- ACHV Nasdaq
- CFBK Nasdaq
- Market Cap
- ACHV 167.6M
- CFBK 151.6M
- IPO Year
- ACHV N/A
- CFBK 1998
- Fundamental
- Price
- ACHV $4.81
- CFBK $23.36
- Analyst Decision
- ACHV Strong Buy
- CFBK Buy
- Analyst Count
- ACHV 1
- CFBK 1
- Target Price
- ACHV $12.00
- CFBK $29.00
- AVG Volume (30 Days)
- ACHV 2.4M
- CFBK 21.0K
- Earning Date
- ACHV 11-06-2025
- CFBK 11-03-2025
- Dividend Yield
- ACHV N/A
- CFBK 1.37%
- EPS Growth
- ACHV N/A
- CFBK 21.79
- EPS
- ACHV N/A
- CFBK 2.49
- Revenue
- ACHV N/A
- CFBK $50,724,000.00
- Revenue This Year
- ACHV N/A
- CFBK $39.98
- Revenue Next Year
- ACHV N/A
- CFBK $10.47
- P/E Ratio
- ACHV N/A
- CFBK $9.36
- Revenue Growth
- ACHV N/A
- CFBK 14.25
- 52 Week Low
- ACHV $1.84
- CFBK $19.23
- 52 Week High
- ACHV $5.78
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- ACHV 61.90
- CFBK 43.94
- Support Level
- ACHV $4.65
- CFBK $22.90
- Resistance Level
- ACHV $5.42
- CFBK $23.97
- Average True Range (ATR)
- ACHV 0.44
- CFBK 0.46
- MACD
- ACHV 0.02
- CFBK 0.01
- Stochastic Oscillator
- ACHV 64.34
- CFBK 56.44
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.